Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

23 Jul 2025 07:00

RNS Number : 1038S
Wilmington PLC
23 July 2025
 

23 July 2025

Wilmington plc

 

Year-end trading update

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2025.

 

Revenue growth from the Group's ongoing* businesses is expected to be 11%, led by both recent acquisitions in the HSE sector delivering double-digit percentage growth.

 

As at the half year, seven out of nine businesses grew year on year. Following the portfolio changes last year of two disposals and two acquisitions, and the continuing disruption in the US healthcare insurance market impacting our US events business over a full year, reported revenue is expected to be £101.5m (2024: £126m), with organic** revenue also having decreased 1% due to the US.

 

Operating profit from ongoing* businesses is expected to be up 11%, adjusted*** profit before tax is expected to be £27.7m (2024: £27.6m), with adjusted PBT margin up to 27% (2024: 22%).

 

Cash conversion continued to be strong at 107% of profits, with Group net cash on 30 June 2025 at £41.9m (30 June 2024: £67.8m) after the completion of the acquisition of Phoenix Health & Safety on 25 October 2024 and spending £3.4m on share buybacks.

 

Wilmington expects to publish its year end results on 22 September 2025.

 

Mark Milner, Chief Executive Officer, commented:

 

"We have seen another year of good ongoing* revenue and profit growth with both measures increasing 11%, reflecting our focus on a slimmed down higher quality portfolio of growing businesses. Margins have also continued to improve and both of our recent acquisitions have seen double digit growth. This performance came against a tough macro backdrop, particularly in the US healthcare market which has seen continued disruption in the course of our H2.

 

"With the acquisition of Phoenix, we have continued to actively manage our portfolio of businesses and are pursuing various opportunities to invest our cash in acquisitions to improve the quality of revenue and profits."

 

*Ongoing - eliminating the effects of the impact of disposals, closures and businesses held for sale.

**Organic - Ongoing, eliminating acquisitions and exchange rate fluctuations

***Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation and impairment of intangible assets (except computer software) and profits/losses on disposals and business closures. Market consensus adjusted profit before tax is £27.0m.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs around 600 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUUORVWUBUAR
Date   Source Headline
21st Aug 20074:45 pmRNSTransaction in Own Shares
20th Aug 20072:55 pmRNSHolding(s) in Company
17th Aug 20076:09 pmRNSTransaction in Own Shares
16th Aug 20074:30 pmRNSTransaction in Own Shares
15th Aug 20077:01 amRNSDisposal of Non-Core Assets
13th Aug 20076:08 pmRNSHolding(s) in Company
13th Aug 20075:16 pmRNSTransaction in Own Shares
10th Aug 20077:00 amRNSNotice of Results
9th Aug 20074:41 pmRNSTransaction in Own Shares
7th Aug 20074:59 pmRNSTransaction in Own Shares
3rd Aug 20074:59 pmRNSTransaction in Own Shares
1st Aug 20075:13 pmRNSVoting Rights and Capital
31st Jul 20075:10 pmRNSTransaction in Own Shares
30th Jul 20075:18 pmRNSTransaction in Own Shares
26th Jul 20075:33 pmRNSTransaction in Own Shares
25th Jul 20075:26 pmRNSTransaction in Own Shares
20th Jul 20075:44 pmRNSShare buy-back programme
20th Jul 20077:00 amRNSPre-Close Trading Update
6th Jun 20077:00 amRNSProposed Disposal
22nd May 200710:43 amRNSHolding(s) in Company
22nd May 200710:35 amRNSHolding(s) in Company
14th May 20073:23 pmRNSDisposal of W.D.I.S. Limited
26th Mar 20077:01 amRNSChange of Adviser
1st Mar 20077:03 amRNSInterim Results
27th Feb 200710:32 amRNSHolding(s) in Company
30th Jan 200712:36 pmRNSNotice of Results
26th Jan 20075:44 pmRNSHolding(s) in Company
15th Dec 20062:54 pmRNSDirector/PDMR Shareholding
14th Dec 20067:00 amRNSTrading Statement
13th Dec 200611:02 amRNSDirector/PDMR Shareholding
12th Dec 20063:29 pmRNSTotal Voting Rights
7th Dec 200611:18 amRNSDirector/PDMR Shareholding
16th Nov 20062:23 pmRNSAnnual Information Update
15th Nov 20065:38 pmRNSAGM Statement
15th Nov 20065:04 pmRNSHolding(s) in Company
14th Nov 20063:13 pmRNSHolding(s) in Company
26th Oct 20064:05 pmRNSAnnual Report and Accounts
23rd Oct 200611:54 amRNSDirector/PDMR Shareholding
16th Oct 20067:01 amRNSAcquisition
21st Sep 20064:19 pmRNSDirector/PDMR Shareholding
18th Sep 20067:02 amRNSFinal Results
12th Sep 20065:31 pmRNSHolding(s) in Company
30th Aug 20062:51 pmRNSNotice of Results
21st Aug 20067:01 amRNSTermination of Discussions
21st Aug 20067:00 amRNSMerger Terminated
14th Aug 200610:41 amRNSRule 8.3- Wilmington Group
10th Aug 20061:28 pmRNSResult of EGM - Adjournment
9th Aug 20069:03 amRNSAdjournment of EGM
9th Aug 20067:00 amRNSAdjournment of EGM
7th Aug 20062:44 pmRNSRule 8.3- Wilmington Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.